TrialThe oncologist2024

A Phase II Study of Neoadjuvant PLD/Cyclophosphamide and Sequential nab-Paclitaxel Plus Dual HER2 Blockade in HER2-Positive Breast Cancer.

Ji-Xin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.